MPX-004

Modify Date: 2025-08-27 19:32:33

MPX-004 Structure
MPX-004 structure
Common Name MPX-004
CAS Number 1688684-07-2 Molecular Weight 455.91
Density N/A Boiling Point N/A
Molecular Formula C17H15ClFN5O3S2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of MPX-004


MPX-004 is a potent GluN2A antagonist. MPX-004 inhibits GluN2A-containing NMDA receptors expressed in HEK cells with an IC50 of 79 nM. MPX-004 has no inhibitory effect on GluN2B or GluN2D receptor-mediated responses. MPX-004 has the potential for neuropsychiatric and developmental disorders research[1].

 Names

Name MPX-004

 MPX-004 Biological Activity

Description MPX-004 is a potent GluN2A antagonist. MPX-004 inhibits GluN2A-containing NMDA receptors expressed in HEK cells with an IC50 of 79 nM. MPX-004 has no inhibitory effect on GluN2B or GluN2D receptor-mediated responses. MPX-004 has the potential for neuropsychiatric and developmental disorders research[1].
Related Catalog
Target

NMDA Receptor

In Vitro MPX-004 抑制表达人 GluN1+GluN2A 的 Xenopus 卵母细胞中 NMDA 受体介导的电流,IC50 为 198 nM。在 10 μM 时,MPX-004 仅微弱地抑制表达 GluN2B、C 或 D 受体的卵母细胞或对照卵母细胞中的电流 (约8%)[1]。 MPX-004 (100 nM-30 μM; 0-50 分钟) 在 3 至 4 周龄大鼠大脑制备的海马切片导致 CA1 区 NMDA 受体介导的 fEPSP 浓度依赖性降低,以响应 Schaffer 侧支刺激[1]。 MPX-004 (1 μM) 抑制 5-HT1B 拮抗剂结合 (35%),5-HT2A 激动剂结合 (31%) 和 EP4 激动剂结合 (27%)。MPX-004 (50 μM) 对小鼠视觉皮层电流切片中锥体神经元的 AMPA 受体介导的突触电流没有影响[1]。
References

[1]. Robert A Volkmann, et al. MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit. PLoS One. 2016 Feb 1;11(2):e0148129.  

 Chemical & Physical Properties

Molecular Formula C17H15ClFN5O3S2
Molecular Weight 455.91
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
Jdr 004
19395-50-7
tme-004
21277-98-5
MOLPORT-004-254-643
1005074-44-1
ZL-004
1015064-87-5
TP-004
1454299-21-8
TSN-004 3',5'-TIPDS-rU3',5'-O-(1,1,3,3-tetraisopropyl-1,3-dis iloxanediyl) uridine
156125-57-4
KX1-004
518058-84-9
Diindolo[3,2-b:3',2'-m]triphenodioxazinesulfonic acid, 8,18-dichloro-5,15-diethyl-5,15-dihydro-, (4-methyl-1H-imidazolyl)methyl derivs., acetates
85186-20-5
ONO-DI 004
250605-97-1
1-[(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3,3-dimethylbutanoyl]-3-methylpiperidine-3-carboxylic acid
2171306-27-5
3-ethyl-1-[(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3,3-dimethylbutanoyl]pyrrolidine-3-carboxylic acid
2171340-40-0
5-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3,3-dimethylbutanamido]-3-methyl-1,2-thiazole-4-carboxylic acid
2171740-71-7
3-{1-[(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3,3-dimethylbutanoyl]pyrrolidin-3-yl}propanoic acid
2171437-59-3
2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3,3-dimethylbutanamido]-2-(thiophen-2-yl)acetic acid
2171636-05-6
(2R)-2-{[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methyloxolan-3-yl]formamido}-3,3-dimethylbutanoic acid
2171418-62-3
(2R)-2-{[1-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclohexyl]formamido}-3,3-dimethylbutanoic acid
2171207-48-8
(2R)-2-({1-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)phenyl]cyclopropyl}formamido)propanoic acid
2171191-88-9
1-{4-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]phenyl}cyclopropane-1-carboxylic acid
2171872-33-4
(2S)-2-({1-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)phenyl]cyclopropyl}formamido)propanoic acid
2171140-18-2